LunarCrush LLM | creator/twitter::932876592644177920/posts

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Biotech_Beast](/creator/twitter/Biotech_Beast)
"$TARS (I'm long) used to talk about Xdemvy being a potential $1B drug but now the company thinks its potential is even higher. Net product sales passed $100M in Q2'25 and the company suggests the effect of the DTC campaign is yet to truly kick in"  
[X Link](https://x.com/Biotech_Beast/status/1971628178608476574) [@Biotech_Beast](/creator/x/Biotech_Beast) 2025-09-26T17:29Z 1762 followers, XXX engagements


"Of course $TARS could have issues a trial in ocular rosacea is set to start in H2'25 and delays or a disappointing result could hit the stock but I still like the name here"  
[X Link](https://x.com/Biotech_Beast/status/1971628560579445226) [@Biotech_Beast](/creator/x/Biotech_Beast) 2025-09-26T17:30Z 1762 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biotech_Beast "$TARS (I'm long) used to talk about Xdemvy being a potential $1B drug but now the company thinks its potential is even higher. Net product sales passed $100M in Q2'25 and the company suggests the effect of the DTC campaign is yet to truly kick in"
X Link @Biotech_Beast 2025-09-26T17:29Z 1762 followers, XXX engagements

"Of course $TARS could have issues a trial in ocular rosacea is set to start in H2'25 and delays or a disappointing result could hit the stock but I still like the name here"
X Link @Biotech_Beast 2025-09-26T17:30Z 1762 followers, XXX engagements